US Authorises Pfizer's Covid Booster For Elderly And High-Risk Adults

The United States on Wednesday authorized the use of boosters of Pfizer's Covid-19 vaccine for people aged over 65, or adults at high-risk of severe disease as well as those in high-exposure jobs.